menu toggle

Cell and Gene Therapy Events


Groundbreaking gene therapies are paving the path to a healthier tomorrow. Join us at an exciting series of industry conferences to discuss  your advanced therapies supply chain and commercialization challenges.

We encourage you to network with us in person, attend our educational and interactive sessions and learn more about our integrated solutions that will help you position your therapies for success.

April 15 - 16, 2024

Cell and Gene Therapy Summit

Under the stewardship of The Economist editors, this second annual summit on cell and gene therapies will convene industry decision-makers to accelerate access to transformative products.

Join our team in Brussels, to discuss how to expedite your therapies to market.

headshot

April 16, 2024 at 2:40pm CEST

From theory to practice: The market impact of HTA legislation

Principal Consultant, Ann-Sophie Kuschel, will join a panel of experts to discuss the impact of Health Technology Assessment (HTA) legislation and the upcoming Joint Clinical Assessment (JCA) on advanced therapies and medicinal products.

May 14-15, 2024 |  8am – 11am PDT / 11am – 2pm EDT / 4pm – 7pm BST / 5pm – 8pm CET 

ThinkLive Cell and Gene Therapy Summit

Join us for our inaugural biopharma event dedicated to exploring the future of cell and gene therapy (CGT). This two-day virtual summit will bring together global and emerging company leaders, providers, and experts who are shaping the future of healthcare.

Cell and Gene Therapy Solutions 

See solutions that enable connections

As healthcare advances, so much the process that connect patients to the therapies they need. Each patient's path to treatment is unique.  And because a rapidly evolving cell therapy market requires an equally innovative partner, AmerisourceBergen is committed to delivering solutions that enable this connection. 

Build your advanced therapy supply chain

Managing critical shipments for advanced therapy developers since 2005, through a network of 120+ facilities, a full range of cryogenic shippers and a single quality system, World Courier helps manufacturers build robust logistics platforms that support the clinical development and commercialization of therapies to meet patient treatment needs.

Take the direct route to commercializing

Finding a commercialization partner is critical. Innovators must choose a partner with extensive connections, knowledge of local regulatory requirements and the international footprint necessary to realize economies of scale. Cencora draws on expertise from years of bringing complex therapies to market, meeting the demands of emerging therapies and the patients who need them.

Additional Insights

Evaluating alternative revolutionary reimbursement models to craft a sustainable business model for cell and gene therapies

During Reuter’s Cell & Gene Therapy USA 2022, Senior VP, Market Economics, David Senior, was joined by fellow industry experts from Bayer, Novartis Gene Therapies, and Point 32, to discuss new innovative payment strategies for cell and gene therapies.

Cell and Gene Therapy Roundup: What the road to success looks like

Over the last few weeks, our team members participated in some of the sector’s most-attended conferences. Read our VP, Cell and Gene Therapy’s insights on the key highlights of these events and how to tackle the challenges ahead.

TrakCel briefing: The evolving digitalization of supply chains

VP, Cell and Gene Therapy, Lung-I Cheng, was invited to join TrakCel’s breakfast briefing during the CAR-TCR Summit 2022 to discuss considerations for enabling treatment and commercial outcomes for advanced therapies, and how orchestration processes will help make speed to therapy attainable.